Advertisement

Topics

CSL Behring wins approval for first subcutaneous HAE therapy

09:47 EDT 23 Jun 2017 | thePharmaLetter

Haegarda, a therapy for hereditary angioedema (HAE) from biotech firm CSL Behring, has been approved…

Original Article: CSL Behring wins approval for first subcutaneous HAE therapy

NEXT ARTICLE

More From BioPortfolio on "CSL Behring wins approval for first subcutaneous HAE therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...